Jump to content

Coronavirus Mega-Thread.


numnuts
 Share

Message added by Grumpy Owl,

This topic is for all general discussion regarding the current COVID-19 pandemic. There are of course numerous other related topics for discussing specific aspects of this pandemic in more detail. And there are other parts of this forum for more 'off-topic' discussions.

Recommended Posts

3 hours ago, skitzorat said:

E9ZI4fnVIAMkRzc.jpg.496958fb64ed8b1b4d0f0f271baf78cc.jpg

Great post. Wonder what method the government will use to turn the zombies on the truckers. Gonna blame them for all deaths as well. Let’s hope the majority support the truckers so that Australia can begin its March to freedom!

Link to comment
Share on other sites

5 hours ago, DarianF said:

There seems to be a lot of hard evidence that some shady shit was indeed going on in the Wuhan lab and Fauci was behind it

 

Indeed there is.. 

But it's all planned theatre to set up the narrative for the 'accidentally released bio-weapon'. 

Theatre to make the masses believe in a new / novel virus. 

 

Accidentally released bio-weapons would kill Billions.

 

  • Like 4
Link to comment
Share on other sites

tomorrow ['Suppression of speech and mandates for an experimental vaccination, are these really for your own safety? Attorney Thomas Renz and DR. Eric Nepute join the table'] and the next few weekdays and next week on the Christian channel 'Daystar' programme called 'Joni Table Talk'  at 4pm(Ch. 583 on Sky) is discussion on covid and the vaccine.

 

today they discuss transhumanism.

Edited by Given To Fly
  • Like 1
Link to comment
Share on other sites

4 hours ago, Dazzer said:

Can you post a link to this photo? Where did you find it? 

 

I downloaded it from Telegram, but I've been on so many Telegram sites lately I can't remember who posted it. Telegram has no History setting.

 

If I come across it again I'll post the details. The name is on the tip of my tongue so it may come back to me soon.

 

 

 

Link to comment
Share on other sites

28 minutes ago, webtrekker said:

 

I downloaded it from Telegram, but I've been on so many Telegram sites lately I can't remember who posted it. Telegram has no History setting.

 

If I come across it again I'll post the details. The name is on the tip of my tongue so it may come back to me soon.

 

 

 

https://www.businessinsider.com/photos-from-the-march-against-terrorism-in-paris-2015-1

  • Thanks 1
Link to comment
Share on other sites

1 hour ago, Bombadil said:

 

 

I remember reading this back then, pur in your face telling us whats going to happen and it spooked the hell out of me.

 

It seemed immpossible back then, but now it nearly seems inevitable.

Humanity is now currently in a fight for it's very survival, and the sad thing is that the majority of Humans are actually aiding the side who are bent on their destruction.

Sadder still, is the fact that we could win this war within 24 hrs, if people would just wake up.

  • Like 3
Link to comment
Share on other sites

5 minutes ago, bamboozooka said:

EDIT - THIS IS NOT CORRECT - EP. 2: WTF!!! PFIZER VACCINE NOT APPROVED! THEY'RE TRYING TO FOOL US!

https://www.bitchute.com/video/ZyhflBIrBDwk/

See the link below?

 

https://www.fda.gov/news-events/press-announcements/fda-approves-first-covid-19-vaccine

 

FDA Approves First COVID-19 Vaccine

Approval Signifies Key Achievement for Public Health

For Immediate Release:
August 23, 2021

 

Español

Today, the U.S. Food and Drug Administration approved the first COVID-19 vaccine. The vaccine has been known as the Pfizer-BioNTech COVID-19 Vaccine, and will now be marketed as Comirnaty (koe-mir’-na-tee), for the prevention of COVID-19 disease in individuals 16 years of age and older. The vaccine also continues to be available under emergency use authorization (EUA), including for individuals 12 through 15 years of age and for the administration of a third dose in certain immunocompromised individuals.

“The FDA’s approval of this vaccine is a milestone as we continue to battle the COVID-19 pandemic. While this and other vaccines have met the FDA’s rigorous, scientific standards for emergency use authorization, as the first FDA-approved COVID-19 vaccine, the public can be very confident that this vaccine meets the high standards for safety, effectiveness, and manufacturing quality the FDA requires of an approved product,” said Acting FDA Commissioner Janet Woodcock, M.D. “While millions of people have already safely received COVID-19 vaccines, we recognize that for some, the FDA approval of a vaccine may now instill additional confidence to get vaccinated. Today’s milestone puts us one step closer to altering the course of this pandemic in the U.S.” 

Since Dec. 11, 2020, the Pfizer-BioNTech COVID-19 Vaccine has been available under EUA in individuals 16 years of age and older, and the authorization was expanded to include those 12 through 15 years of age on May 10, 2021. EUAs can be used by the FDA during public health emergencies to provide access to medical products that may be effective in preventing, diagnosing, or treating a disease, provided that the FDA determines that the known and potential benefits of a product, when used to prevent, diagnose, or treat the disease, outweigh the known and potential risks of the product.

FDA-approved vaccines undergo the agency’s standard process for reviewing the quality, safety and effectiveness of medical products. For all vaccines, the FDA evaluates data and information included in the manufacturer’s submission of a biologics license application (BLA). A BLA is a comprehensive document that is submitted to the agency providing very specific requirements. For Comirnaty, the BLA builds on the extensive data and information previously submitted that supported the EUA, such as preclinical and clinical data and information, as well as details of the manufacturing process, vaccine testing results to ensure vaccine quality, and inspections of the sites where the vaccine is made. The agency conducts its own analyses of the information in the BLA to make sure the vaccine is safe and effective and meets the FDA’s standards for approval. 

Comirnaty contains messenger RNA (mRNA), a kind of genetic material. The mRNA is used by the body to make a mimic of one of the proteins in the virus that causes COVID-19. The result of a person receiving this vaccine is that their immune system will ultimately react defensively to the virus that causes COVID-19. The mRNA in Comirnaty is only present in the body for a short time and is not incorporated into - nor does it alter - an individual’s genetic material. Comirnaty has the same formulation as the EUA vaccine and is administered as a series of two doses, three weeks apart. 

“Our scientific and medical experts conducted an incredibly thorough and thoughtful evaluation of this vaccine. We evaluated scientific data and information included in hundreds of thousands of pages, conducted our own analyses of Comirnaty’s safety and effectiveness, and performed a detailed assessment of the manufacturing processes, including inspections of the manufacturing facilities,” said Peter Marks, M.D., Ph.D., director of FDA’s Center for Biologics Evaluation and Research. “We have not lost sight that the COVID-19 public health crisis continues in the U.S. and that the public is counting on safe and effective vaccines. The public and medical community can be confident that although we approved this vaccine expeditiously, it was fully in keeping with our existing high standards for vaccines in the U.S."

FDA Evaluation of Safety and Effectiveness Data for Approval for 16 Years of Age and Older

The first EUA, issued Dec. 11, for the Pfizer-BioNTech COVID-19 Vaccine for individuals 16 years of age and older was based on safety and effectiveness data from a randomized, controlled, blinded ongoing clinical trial of thousands of individuals. 

To support the FDA’s approval decision today, the FDA reviewed updated data from the clinical trial which supported the EUA and included a longer duration of follow-up in a larger clinical trial population. 

Specifically, in the FDA’s review for approval, the agency analyzed effectiveness data from approximately 20,000 vaccine and 20,000 placebo recipients ages 16 and older who did not have evidence of the COVID-19 virus infection within a week of receiving the second dose. The safety of Comirnaty was evaluated in approximately 22,000 people who received the vaccine and 22,000 people who received a placebo 16 years of age and older.

Based on results from the clinical trial, the vaccine was 91% effective in preventing COVID-19 disease. 

More than half of the clinical trial participants were followed for safety outcomes for at least four months after the second dose. Overall, approximately 12,000 recipients have been followed for at least 6 months.

The most commonly reported side effects by those clinical trial participants who received Comirnaty were pain, redness and swelling at the injection site, fatigue, headache, muscle or joint pain, chills, and fever. The vaccine is effective in preventing COVID-19 and potentially serious outcomes including hospitalization and death.

Additionally, the FDA conducted a rigorous evaluation of the post-authorization safety surveillance data pertaining to myocarditis and pericarditis following administration of the Pfizer-BioNTech COVID-19 Vaccine and has determined that the data demonstrate increased risks, particularly within the seven days following the second dose. The observed risk is higher among males under 40 years of age compared to females and older males. The observed risk is highest in males 12 through 17 years of age. Available data from short-term follow-up suggest that most individuals have had resolution of symptoms. However, some individuals required intensive care support. Information is not yet available about potential long-term health outcomes. The Comirnaty Prescribing Information includes a warning about these risks.

Ongoing Safety Monitoring

The FDA and Centers for Disease Control and Prevention have monitoring systems in place to ensure that any safety concerns continue to be identified and evaluated in a timely manner. In addition, the FDA is requiring the company to conduct postmarketing studies to further assess the risks of myocarditis and pericarditis following vaccination with Comirnaty. These studies will include an evaluation of long-term outcomes among individuals who develop myocarditis following vaccination with Comirnaty. In addition, although not FDA requirements, the company has committed to additional post-marketing safety studies, including conducting a pregnancy registry study to evaluate pregnancy and infant outcomes after receipt of Comirnaty during pregnancy.

The FDA granted this application Priority Review. The approval was granted to BioNTech Manufacturing GmbH.

Edited by The Andernovian
text inserterd
Link to comment
Share on other sites

2 minutes ago, The Andernovian said:

 

Declared "safe" for over 16 year olds only... you can see the agenda here, it's all about mandating the vax in work and leisure venues for adults... for the time being, then they come for the kids.

All about the vaccine passport folks. 😡

  • Like 2
Link to comment
Share on other sites

8 minutes ago, Roscommon said:

Sadder still, is the fact that we could win this war within 24 hrs, if people would just wake up.

 

I hope people get behind these truckies in Australia, this could really gain traction if they get the support they need... 👍

Edited by HAARPING_On
Removed text
  • Thanks 1
Link to comment
Share on other sites

5 hours ago, skitzorat said:

E9ZI4fnVIAMkRzc.jpg.496958fb64ed8b1b4d0f0f271baf78cc.jpg

 

Won't work unless they block the roads as well.  Otherwise the authorities will just use the armed forces to drive supply lorries, etc.  They can also bribe enough lorry drivers to keep things going.

Edited by Ergo Storm
Link to comment
Share on other sites

5 hours ago, Dazzer said:

Can you post a link to this photo? Where did you find it? 

 

50 minutes ago, webtrekker said:

I downloaded it from Telegram, but I've been on so many Telegram sites lately I can't remember who posted it. Telegram has no History setting.

 

If I come across it again I'll post the details. The name is on the tip of my tongue so it may come back to me soon.

 

That's an old protest picture from 2015 after Charlie Hebdo attacks.

https://www.rfi.fr/en/france/20150113-france-deploys-10500-troops-after-Charlie-Hebdo-attacks

Link to comment
Share on other sites

3 hours ago, zArk said:

wtf.

has the jab manifested the Germ theory dream of transmission?

2 year olds menstruating blood clots ......

 

or

like with the story a few months ago of women in the same room as the jabbed menstruating blood clots is this an EM poisoning ?

 

When the data is thoroughly examined and all environmental factors are included USUALLY in the cases of 'spread' or 'transmission' a common environmental toxin is discovered

 

 

I'm not sure if by that time there will be anyone left to investigate anything. 

Link to comment
Share on other sites

2 hours ago, eddy64 said:

 

 

that's funny i thought ivermectin was widely used in Africa to treat parasite infections in humans and treat thing like river blindness, has been used for decades afaik.

 

https://www.who.int/tdr/news/2018/moxidectin-approved-as-treatment-for-river-blindness/en/

I wonder what they didn't  use on Africans - ah I know - covid vaccine ;)))

Link to comment
Share on other sites

37 minutes ago, The Andernovian said:

See the link below?

 

https://www.fda.gov/news-events/press-announcements/fda-approves-first-covid-19-vaccine

 

FDA Approves First COVID-19 Vaccine

Approval Signifies Key Achievement for Public Health

For Immediate Release:
August 23, 2021

 

Español

Today, the U.S. Food and Drug Administration approved the first COVID-19 vaccine. The vaccine has been known as the Pfizer-BioNTech COVID-19 Vaccine, and will now be marketed as Comirnaty (koe-mir’-na-tee), for the prevention of COVID-19 disease in individuals 16 years of age and older. The vaccine also continues to be available under emergency use authorization (EUA), including for individuals 12 through 15 years of age and for the administration of a third dose in certain immunocompromised individuals.

“The FDA’s approval of this vaccine is a milestone as we continue to battle the COVID-19 pandemic. While this and other vaccines have met the FDA’s rigorous, scientific standards for emergency use authorization, as the first FDA-approved COVID-19 vaccine, the public can be very confident that this vaccine meets the high standards for safety, effectiveness, and manufacturing quality the FDA requires of an approved product,” said Acting FDA Commissioner Janet Woodcock, M.D. “While millions of people have already safely received COVID-19 vaccines, we recognize that for some, the FDA approval of a vaccine may now instill additional confidence to get vaccinated. Today’s milestone puts us one step closer to altering the course of this pandemic in the U.S.” 

Since Dec. 11, 2020, the Pfizer-BioNTech COVID-19 Vaccine has been available under EUA in individuals 16 years of age and older, and the authorization was expanded to include those 12 through 15 years of age on May 10, 2021. EUAs can be used by the FDA during public health emergencies to provide access to medical products that may be effective in preventing, diagnosing, or treating a disease, provided that the FDA determines that the known and potential benefits of a product, when used to prevent, diagnose, or treat the disease, outweigh the known and potential risks of the product.

FDA-approved vaccines undergo the agency’s standard process for reviewing the quality, safety and effectiveness of medical products. For all vaccines, the FDA evaluates data and information included in the manufacturer’s submission of a biologics license application (BLA). A BLA is a comprehensive document that is submitted to the agency providing very specific requirements. For Comirnaty, the BLA builds on the extensive data and information previously submitted that supported the EUA, such as preclinical and clinical data and information, as well as details of the manufacturing process, vaccine testing results to ensure vaccine quality, and inspections of the sites where the vaccine is made. The agency conducts its own analyses of the information in the BLA to make sure the vaccine is safe and effective and meets the FDA’s standards for approval. 

Comirnaty contains messenger RNA (mRNA), a kind of genetic material. The mRNA is used by the body to make a mimic of one of the proteins in the virus that causes COVID-19. The result of a person receiving this vaccine is that their immune system will ultimately react defensively to the virus that causes COVID-19. The mRNA in Comirnaty is only present in the body for a short time and is not incorporated into - nor does it alter - an individual’s genetic material. Comirnaty has the same formulation as the EUA vaccine and is administered as a series of two doses, three weeks apart. 

“Our scientific and medical experts conducted an incredibly thorough and thoughtful evaluation of this vaccine. We evaluated scientific data and information included in hundreds of thousands of pages, conducted our own analyses of Comirnaty’s safety and effectiveness, and performed a detailed assessment of the manufacturing processes, including inspections of the manufacturing facilities,” said Peter Marks, M.D., Ph.D., director of FDA’s Center for Biologics Evaluation and Research. “We have not lost sight that the COVID-19 public health crisis continues in the U.S. and that the public is counting on safe and effective vaccines. The public and medical community can be confident that although we approved this vaccine expeditiously, it was fully in keeping with our existing high standards for vaccines in the U.S."

FDA Evaluation of Safety and Effectiveness Data for Approval for 16 Years of Age and Older

The first EUA, issued Dec. 11, for the Pfizer-BioNTech COVID-19 Vaccine for individuals 16 years of age and older was based on safety and effectiveness data from a randomized, controlled, blinded ongoing clinical trial of thousands of individuals. 

To support the FDA’s approval decision today, the FDA reviewed updated data from the clinical trial which supported the EUA and included a longer duration of follow-up in a larger clinical trial population. 

Specifically, in the FDA’s review for approval, the agency analyzed effectiveness data from approximately 20,000 vaccine and 20,000 placebo recipients ages 16 and older who did not have evidence of the COVID-19 virus infection within a week of receiving the second dose. The safety of Comirnaty was evaluated in approximately 22,000 people who received the vaccine and 22,000 people who received a placebo 16 years of age and older.

Based on results from the clinical trial, the vaccine was 91% effective in preventing COVID-19 disease. 

More than half of the clinical trial participants were followed for safety outcomes for at least four months after the second dose. Overall, approximately 12,000 recipients have been followed for at least 6 months.

The most commonly reported side effects by those clinical trial participants who received Comirnaty were pain, redness and swelling at the injection site, fatigue, headache, muscle or joint pain, chills, and fever. The vaccine is effective in preventing COVID-19 and potentially serious outcomes including hospitalization and death.

Additionally, the FDA conducted a rigorous evaluation of the post-authorization safety surveillance data pertaining to myocarditis and pericarditis following administration of the Pfizer-BioNTech COVID-19 Vaccine and has determined that the data demonstrate increased risks, particularly within the seven days following the second dose. The observed risk is higher among males under 40 years of age compared to females and older males. The observed risk is highest in males 12 through 17 years of age. Available data from short-term follow-up suggest that most individuals have had resolution of symptoms. However, some individuals required intensive care support. Information is not yet available about potential long-term health outcomes. The Comirnaty Prescribing Information includes a warning about these risks.

Ongoing Safety Monitoring

The FDA and Centers for Disease Control and Prevention have monitoring systems in place to ensure that any safety concerns continue to be identified and evaluated in a timely manner. In addition, the FDA is requiring the company to conduct postmarketing studies to further assess the risks of myocarditis and pericarditis following vaccination with Comirnaty. These studies will include an evaluation of long-term outcomes among individuals who develop myocarditis following vaccination with Comirnaty. In addition, although not FDA requirements, the company has committed to additional post-marketing safety studies, including conducting a pregnancy registry study to evaluate pregnancy and infant outcomes after receipt of Comirnaty during pregnancy.

The FDA granted this application Priority Review. The approval was granted to BioNTech Manufacturing GmbH.

This made it safe and effective 🤣

Link to comment
Share on other sites

9 minutes ago, Human10 said:

I wonder what they didn't  use on Africans - ah I know - covid vaccine ;)))

 

 

sorry seem to have quoted the wrong link, was sure it said ivermectin earlier.

 

EDIT: it does mention ivermectin.  a few more links in case the first article is edited to remove references to it.

 

 

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(18)30101-6/fulltext

 

https://www.cdc.gov/parasites/onchocerciasis/treatment.html

 

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4425412/

 

Edited by eddy64
Link to comment
Share on other sites

5 hours ago, Dazzer said:

Maybe somebody should show her photos of Obama's birthday party, or how about the G7 meeting? 

Her retarded son wouldn't develop viral infection if he didn't wear a mask but it's probably to difficult to analyse facts with her covid brain... Didn't she mention he was the only one of 300 wearing it?? Masks work! 🤭

Link to comment
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

 Share

×
×
  • Create New...